Published in J Cardiovasc Magn Reson on July 02, 2010
Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson (2012) 1.51
Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. J Appl Physiol (1985) (2011) 1.21
Troponin elevation in conditions other than acute coronary syndromes. Vasc Health Risk Manag (2011) 1.01
The impact of repeated marathon running on cardiovascular function in the aging population. J Cardiovasc Magn Reson (2012) 0.86
CrossTalk opposing view: Prolonged intense exercise does not lead to cardiac damage. J Physiol (2013) 0.85
Are There Deleterious Cardiac Effects of Acute and Chronic Endurance Exercise? Physiol Rev (2016) 0.82
Nonischemic Left Ventricular Scar as a Substrate of Life-Threatening Ventricular Arrhythmias and Sudden Cardiac Death in Competitive Athletes. Circ Arrhythm Electrophysiol (2016) 0.78
Review of Journal of Cardiovascular Magnetic Resonance 2011. J Cardiovasc Magn Reson (2012) 0.76
'Paracelcus' rediscovered: searching for the right dose of physical training. Open Heart (2014) 0.75
Review of journal of cardiovascular magnetic resonance 2010. J Cardiovasc Magn Reson (2011) 0.75
The Right Heart: Acute and Chronic Issues. Curr Treat Options Cardiovasc Med (2017) 0.75
An improved MR imaging technique for the visualization of myocardial infarction. Radiology (2001) 7.45
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol (2009) 6.41
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol (2002) 5.74
Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson (2008) 5.65
Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol (2005) 5.50
Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation (2007) 5.09
Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation (1998) 3.99
Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol (2004) 3.85
"Black blood" T2-weighted inversion-recovery MR imaging of the heart. Radiology (1996) 3.34
Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study. J Am Coll Cardiol (2009) 2.90
Relation of biomarkers and cardiac magnetic resonance imaging after marathon running. Am J Cardiol (2009) 2.57
Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. Circulation (2006) 2.40
Persistent and reversible cardiac dysfunction among amateur marathon runners. Eur Heart J (2006) 1.88
Cardiac troponin T release is stimulated by endurance exercise in healthy humans. J Am Coll Cardiol (2008) 1.74
Cardiac troponin T alterations in myocardium and serum of rats after stressful, prolonged intense exercise. J Appl Physiol (1985) (2000) 1.71
MRI of acute myocarditis: a comprehensive approach based on various imaging sequences. Chest (2002) 1.64
Myocardial function in older male amateur marathon runners: assessment by tissue Doppler echocardiography, speckle tracking, and cardiac biomarkers. J Am Soc Echocardiogr (2009) 1.63
Extraordinary unremitting endurance exercise and permanent injury to normal heart. Lancet (1992) 1.58
Exercise-induced cardiac troponin T release: a meta-analysis. Med Sci Sports Exerc (2007) 1.27
Myocardial adaptation to short-term high-intensity exercise in highly trained athletes. J Am Soc Echocardiogr (2006) 1.23
Changes in vascular and cardiac function after prolonged strenuous exercise in humans. J Appl Physiol (1985) (2008) 1.21
Impact of marathon running on cardiac structure and function in recreational runners. Clin Sci (Lond) (2005) 1.16
Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy. Eur J Radiol (2009) 1.11
Left ventricular function immediately following prolonged exercise: A meta-analysis. Med Sci Sports Exerc (2006) 1.02
Post-mortem evidence of idiopathic left ventricular hypertrophy and idiopathic interstitial myocardial fibrosis: is exercise the cause? Br J Sports Med (2007) 0.99
MRI detection of myocardial perfusion changes by gadolinium-DTPA infusion during dipyridamole hyperemia. Magn Reson Med (1989) 0.98
MRI changes in myocarditis--evaluation with spin echo, cine MR angiography and contrast enhanced spin echo imaging. Clin Radiol (2000) 0.92
Mitral annular myocardial velocity assessment of segmental left ventricular diastolic function after prolonged exercise in humans. J Physiol (2005) 0.91
Clinical significance of cardiac damage and changes in function after exercise. Med Sci Sports Exerc (2008) 0.91
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med (2010) 15.71
Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet (2002) 6.11
Truncations of titin causing dilated cardiomyopathy. N Engl J Med (2012) 6.07
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol (2002) 5.74
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol (2006) 5.58
Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med (2002) 5.42
Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA (2013) 5.19
Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol (2003) 4.36
Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson (2013) 3.87
Long-term benefits of 5 years of tamoxifen: 10-year follow-up of a large randomized trial in women at least 50 years of age with early breast cancer. J Clin Oncol (2011) 3.73
Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J (2007) 3.65
Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol (2010) 3.50
Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol (2008) 3.42
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med (2016) 3.40
Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J (2004) 3.15
A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging (2003) 3.11
The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J (2007) 3.11
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging (2002) 2.95
Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll Cardiol (2002) 2.87
Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2008) 2.85
Acute-onset floaters and flashes: is this patient at risk for retinal detachment? JAMA (2009) 2.82
Left ventricular mass: reliability of M-mode and 2-dimensional echocardiographic formulas. Hypertension (2002) 2.77
Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol (2007) 2.73
Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina (2008) 2.72
Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation (2012) 2.71
Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol (2011) 2.66
Evaluation of the clinical age-related maculopathy staging system. Ophthalmology (2006) 2.63
Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol (2004) 2.59
Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. Eur Heart J (2008) 2.52
Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study. Am J Respir Crit Care Med (2005) 2.49
Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J (2009) 2.37
Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance. Eur Heart J (2006) 2.35
On T2* magnetic resonance and cardiac iron. Circulation (2011) 2.33
The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol (2004) 2.31
Prevalence and significance of an isolated long QT interval in elite athletes. Eur Heart J (2007) 2.28
Utility of the "surprise" question to identify dialysis patients with high mortality. Clin J Am Soc Nephrol (2008) 2.22
Can ROTEM thromboelastometry predict postoperative bleeding after cardiac surgery? J Cardiothorac Vasc Anesth (2008) 2.20
Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). J Am Coll Cardiol (2009) 2.20
Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia. Blood (2009) 2.20
Do findings on routine examination identify patients at risk for primary open-angle glaucoma? The rational clinical examination systematic review. JAMA (2013) 2.19
Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome. Circulation (2006) 2.18
Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance. Circulation (2002) 2.16
Corticomotor excitability contributes to neuromuscular fatigue following marathon running in man. Exp Physiol (2006) 2.16
Why isn't flow-mediated dilation enhanced in athletes? Med Sci Sports Exerc (2013) 2.15
Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension (2002) 2.11
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol (2003) 2.10
Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J (2003) 2.08
Position paper: proposal for a core curriculum for a European Sports Cardiology qualification. Eur J Prev Cardiol (2012) 2.07
Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J Am Coll Cardiol (2010) 2.06
Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy. Kidney Int (2005) 2.02
Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson (2008) 2.01
Left ventricular wall thickness and the presence of asymmetric hypertrophy in healthy young army recruits: data from the LARGE heart study. Circ Cardiovasc Imaging (2013) 1.98
Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging (2003) 1.96
Regional thicknesses and thickening of compacted and trabeculated myocardial layers of the normal left ventricle studied by cardiovascular magnetic resonance. Circ Cardiovasc Imaging (2010) 1.94
Outcome results in macular hole surgery: an evaluation of internal limiting membrane peeling with and without indocyanine green. Ophthalmology (2003) 1.93
Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis. Circulation (2003) 1.91
A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis (2002) 1.89
Breath-hold FLASH and FISP cardiovascular MR imaging: left ventricular volume differences and reproducibility. Radiology (2002) 1.88
Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohort. Acad Radiol (2011) 1.88
Accurate assessment of the arterial input function during high-dose myocardial perfusion cardiovascular magnetic resonance. J Magn Reson Imaging (2004) 1.86
The right ventricle of the endurance athlete: the relationship between morphology and deformation. J Am Soc Echocardiogr (2011) 1.85
Thalassemia. Hematology Am Soc Hematol Educ Program (2004) 1.83
Health care economic analyses and value-based medicine. Surv Ophthalmol (2003) 1.83
Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. J Cardiovasc Magn Reson (2008) 1.76
Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. Am J Respir Crit Care Med (2009) 1.75
The pathologic basis of Q-wave and non-Q-wave myocardial infarction: a cardiovascular magnetic resonance study. J Am Coll Cardiol (2004) 1.75
Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J Am Coll Cardiol (2008) 1.74
Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma. Blood (2010) 1.74
Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. Circulation (2011) 1.74
Cardiac troponin T release is stimulated by endurance exercise in healthy humans. J Am Coll Cardiol (2008) 1.74
A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins. PLoS One (2007) 1.73
Incremental cost-effectiveness of initial cataract surgery. Ophthalmology (2002) 1.72
Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. J Am Coll Cardiol (2008) 1.71
A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am J Hum Genet (2004) 1.71
Systematic review and meta-analysis of training mode, imaging modality and body size influences on the morphology and function of the male athlete's heart. Heart (2013) 1.68
Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. J Nucl Cardiol (2002) 1.68
Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coll Cardiol (2006) 1.67